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Abstract
Since the 1990s, nutritionists have concluded that poor food hygiene, as well as environmental and food 
pollution, are the cause of the major serious diseases affecting humanity: overweight and obesity, which induce 
persistent systemic pro-inflammatory status, and hence all complications metabolic disorders, cancers, joint 
diseases, skin disorders, psychological disorders. The human body hosts a large number of microbes, including 
bacterial, fungal and protozoal microorganisms, which together constitute our microbe. Dysbiosis, generated by 
a sedentary lifestyle, consuming highly industrialized food, and non-compliance with the mass program, can lead 
to obesity, with a decrease in quality of life and shortening it. Obesity and metabolic disorders related to obesity 
are characterized by specific changes in the composition and function of the human intestinal microbe. Among the 
possible strategies for preventing and/or treating obesity, the microbiota is intended to restore or modulate its 
composition by consuming probiotics, prebiotics or both (synbiotics).
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Introduction
The consumer’s acceptance of food is of a 
subjective nature, based in particular on the pleasure of eating. The pleasure of consuming certain foods is conditioned mainly by their sensory 
qualities, the culture and physiological state of the 
consumer, as well as by other contextual factors 
(Savona et al., 2017).
Today, more and more people suffer from 
a severe imbalance of intestinal microflora, 
dysbiosis, with serious health effects, and appearance of overweight and obesity. The whole organism is affected by the alteration of this 
microbiota, which is multifactorial (changes in the 
human diet, now too rich in ultra-processed foods, 
smoking, lifestyle, stress, pathogens, antibiotic 
use, radiation, etc) (Singh et al., 2017). 
Obesity is a metabolic abnormality, manifested by an increase in body fat mass as a result of a 
positive energy balance, with the prevalence of lipogenesis relative to lipolysis7. However, recent evidence suggests that obesity is a more complicated disease associated with intestinal 
dysbiosis in both mice and humans (Arslan, 2014).
In 2016, more than 1.9 billion adults, 18 
years and older, were overweight, and of these over 650 million were obese. 39% of adults aged 
18 years and over were overweight in 2016, and 
13% were obese. Most of the world’s population live in countries where overweight and obesity 
kills more people than underweight. 41 million children under the age of 5 were overweight or obese in 2016. Over 340 million children and adolescents aged 5-19 were overweight or obese 
in 2016 (WHO, accessed: January 2019).Based on the latest estimates in European 
Union countries, overweight affects 30-70% 
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and obesity affects 10-30% of adults. (WHO, 
accessed: May 2019). For Romania, the available epidemiological data estimate a prevalence of overweight to be 31% of the adult population and 
the prevalence of obesity to be of 21.3% (Roman 
el al., 2015). Obesity is a serious public health problem 
because, in addition to lowering the quality of life 
(Taylor et al., 2013) and life expectancy, there is 
an increased risk of chronic diseases such as type 
2 diabetes, cardiovascular disease, hypertension, 
coronary artery disease (Nuberg et al., 2018), 
certain cancers (Lauby-Secretan et al., 2016), and 
psychological problems. For society as a whole, obesity has direct and indirect costs that burden 
the health system and social resources (Tremmel 
et al., 2017).
In obese individuals, there is a general decrease in bacterial diversity in the intestines 
(De Gruttola et al., 2016). In most studies, both 
in humans and animal models, obesity appears 
to be associated with a modified ratio between 
Bacteroidetes and Firmicutes, showing a decrease in the number of Bacteroidetes while Firmicutes 
increased (Turnbaugh et al., 2006; Hildebrandt et 
al., 2009).
Microbial colonization of the human intestine since the early days of life is a complicated complex 
process, resulting in a symbiotic relationship with the host that maintains its health and homeostasis. The four dominant bacterial phyla in the human gut are Firmicutes, Bacteriodetes, Actinobacteria and Proteobacteria. Most bacteria belong to the genera Bacteroides, Clostridium, Faecalibacterium, 
Eubacterium, Ruminococcus, Peptococcus, 
Peptostreptococcus, and Bifidobacterium. Other 
genera, such as Escherichia and Lactobacillus, are present to a lesse extent. Species from the genus Bacteroides alone constitute about 30% of 
all bacteria in the gut, suggesting that this genus is especially important in the functioning of the host (Guarner et al., 2003). In the healthy young 
intestine, the microbiome has the following dominant composition: Bifidobacterium, 
Escherichia coli, Clostridium, Bacteroides, 
Streptococcus, Enterococcus, and Actinomycetes. 
Bifidobacteria are the first to colonize the human 
intestine, constituting the dominant microbial of 
the infant. The newborn is exposed to beneficial bacteria when passing through a natural canal of 
birth and then through breast milk. Communal 
microorganisms can enter maternal breast milk 
from the mammary skin of area or through the bloodstream after translocation from the maternal 
intestine to mammary glands (Le Doare et al., 
2018).
Obesity	and	its	triggering	factors	
Gestation and early life. Among the factors 
criminalized in an individual’s predisposition to obesity are the environmental and nutritional 
influences in critical developmental periods. Maternal body weight during pregnancy 
can influence the body size, shape and body composition of the fetus. Infants born to mothers 
with type 2 diabetes or who have smoked during 
pregnancy are at greater risk of being overweight as children and adults. Breastfeeding is associated 
with a lower risk of overweight (Lifschitz et al., 
2015).
Childhood and adolescence. The predictive value of childhood obesity varies with age at 
the onset of obesity. Obesity during childhood, 
usually prevalent in adulthood, especially in obese families. Obesity during adolescence is associated with severe obesity in adults with its metabolic 
complications (You et al., 2016).
Adults. In spite of the importance of childhood 
and adolescent weight, most overweight people develop their problem in adult life through changes 
in global food supply, including the availability of 
cheap, palatable, convenient, energy-dense foods, 
sedentary lifestyle, sleep deprivation, cessation 
of smoking. The relationship between diet and obesity may also involve the gut microbiome. Epidemiological data suggest that a diet high in fat and sugar is associated with obesity. In a 
prospective evaluation of three cohorts (120,877 
men and women), increased consumption 
of potato chips, potatoes, sugar-sweetened 
beverages, unprocessed red meat and processed meats was directly associated with weight gain 
(Mozaffarian et al., 2011).
Physiological critical periods such as puberty, 
pregnancy, menopause - may be accompanied by obesity.
Genetic factors. Their importance lies in the family aggregation of cases of obesity. There are 
monogenic conditions that lead to obesity, some 
associated with dysmorphic features ( Prader-
Wili S, Bardet-Biedl S, etc.), most of which are due to mutations in genes of the leptin-melanocortin 
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system (POMC, MC4-R, leptin and its receptor). 
However, obesity occurs in most cases due to subtle alterations of interactions between 
genetic and environmental factors (multifactorial 
determinism). Heritability ranges from 0.6 to 0.9. The newest “whole genome scan” population 
identifies certain common polymorphisms in the 
population as associated with an increased risk of 
obesity: a SNP (mononucleotide polymorphism) 
near the INSIG2 (insulin-induced gene 2) gene 
revealed at 10% of the population, a variant of 
the FTO gene (fat mass and obesity associated) 
may explain 22% of common obesity, according 
to a study. Mutations in the heterozygous form of 
the MC4-R (melanocortin-4 receptor) gene in the 
β3-adrenergic receptor or PPARγ2 (Peroxisome 
proliferator-activated receptor) gene, a nuclear 
transcription factor having a key role in 
differentiating adipocytes, are other examples of 
genes involved in simple obesity (Huvenne et al., 
2016).
Psychogenic and nervous factors such as “binge 
eating” (psychiatric condition characterized 
by uncontrolled excess food, especially in the 
evening) or night feeding episodes.
Drugs. Some drugs administered over a longer period of time cause obesity. These include the 
following: contraceptives, antidepressants (ami-
triptyline, doxepin, lithium, imipramine), antipsy-
chotics (chlorpromazine, risperidone, clozapine), 
antiepileptics (carbamazepine, valproate), ster-
oids (glucocorticoids, estrogens), serotoninergic 
(ciproheptadine) antagonists, insulin, thiazoli-
dinediones (administered inappropriately). The mechanisms by which they produce obesity are those that stimulate appetite.
Metabolic and endocrine factors, such as: hypothyroidism; insulinoma in which hyperinsuli-
nism and excessive food intake promotes the accumulation of fats; the hypercorticism that actually causes a redistribution of adipose panicle and a moderate weight gain; excess cortisol favors adipocyte hypertrophy hypertrophy and fat 
redistribution, plus muscle protein destruction 
that emphasizes the appearance of obesity, the activity of lipoprotein lipase is more pronounced under the action of cortisol in visceral tissue than 
in the subcutaneous tissue in women, as well as 
to the man; hypothalamic disorders - traumas, 
tumors, inflammations are often accompanied 
by obesity due to the hunger, satiety and energy 
consumption control centers; hypogonadism is often accompanied by obesity; weight gain occurs mainly after puberty; polycystic ovary syndrome 
associates a firm obesity without creases, associating signs and symptoms of ovarian 
virilism; adult GH deficiency is accompanied by visceral obesity.
Intestinal microbiota is influenced by several 
factors: ability of bacteria to bind to specific 
enterocyte receptors, altering the functions and morphology of intestinal villitis; food spectrum 
and diet: a permanent intake of meat favors the 
growth of a microflora of putrefaction, while a 
fiber and vegetable-rich regime determines a 
fermentative microflora; gastric acidity: in the case of hypoacidity/achlorhydria the number 
of bacteria multiplies by about 10,000 times in 
the upper intestine (duodenum); this microflora 
becomes anaerobic, rich in lactobacilli, so a pathological state; active peristalsis of the upper 
small intestine tends to move microflora towards the terminal end of the digestive tract; interactions 
between bacteria, either stimulatory or inhibitory have tendency to modify species structure of the microbiota; IgA secreting antibodies produced by intestinal wall plasma cells inhibit microbial proliferation and prevent the adhesion of bacteria to the mucosal epithelium; mucus prevents 
the action of bacteria, while protecting other bacterial species against the destructive action 
of hydrochloric acid, digestive enzymes, and 
digestive enzymes (Thursby and Juge, 2017).One of the roles of colon microbiota is to ferment the substances from the diet that could not be digested in the small intestine. Non-digested 
components are starch-resistant, non-ammonium 
polysaccharides (cellulose, hemicellulose, 
oligosaccharide, protein, etc.).
Intestinal	Microbiota	The intestinal microbiota consists of a com-
plex ecosystem of microorganisms, a number of which grows from 103 germs/ml in the stomach to 104-106 germs/ml in the small intestine, up to 1012 germs/ml in the colon, belonging to over 
500 different species (Alberoni et al., 2018). The human digestive system contains about 1014 
bacteria, that is, ten times more bacterial cells than 
its own cells. For each human gene, there are 100 
bacterial genes that makeup metagenome (Grice 
and Segre, 2012).
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When born naturally, a newborn’s intestine 
is populated with a mother’s natural birth 
microflora, thus borrowing the characteristics of 
the family microbe, being extremely important for 
the future development of the child’s microbiota, 
maturation of the immune system, resistance to 
infections, autoimmune diseases, and generally for his health for the rest of his life. It seems that 
each family develops a specific microbiota that 
is inherited, so an obese mother will transmit a microbiota that predisposes the child to obesity 
(Neu et al., 2011). Natural breast milk stimulates the strong growth of Bifidobacteria, while artificial feeding stimulates the development of Clostridium, 
Bacteroides, Streptococcus genes. With aging, the 
intestinal microbial structure changes, decreasing 
Bifidobacteria, while Lactobacilli, Enterococci, 
Enterobacteria and Clostridia increase in number. This stimulates the development of pathogen-toxic 
processes that increase the risk of overweight, 
cancer and liver dysfunction (Mueller et al., 2015).
Microflora varies quantitatively depending on 
segments of the digestive system: oral microflora has an average abundance; gastric acid is relatively low because gastric acid destroys about 99% of 
germs; microflora being more numerous in the 
thin lower intestine, 106-107/ml and extremely 
abundant in the large intestine, 109-1011/ml, so that bacteria represent more than half the 
weight of the feces. Microflora varies qualitatively depending on the segmental digestive tract: in the 
upper part of the digestive tract (the oral cavity) 
there are exclusive aerobic germs, which will be 
replaced by anaerobic germs, the predominant 
colon (over 99%); in the duodenum and jejunum there are aerobic germs: Enterococci, Streptococci, 
Staphylococci, Enterobacter, Klebsiella, Citrobacter, 
Pseudomonas; the anaerobic germ predominates in 
the ileum portion, and in the colon the microflora 
is strictly anaerobic (Cooper, 2018). It is estimated that the microbiota consists of over 400 bacterial 
species (Grice and Segre, 2012).
Microbiota, in terms of bacterial colonization 
capacity, can be:
- passage microbiota, including bacteria that are unable to attach to the intestinal structures and to develop in this environment;
- resident microbiota able to colonize and develop 
in intestinal structures. This microflora is found in the terminal intestinal tract and in the colon 
(Jandhyala et al., 2015).
Every day, 60-80 g of non-digested foods, which are partially degraded by lactic acid 
fermentation and short chain fatty acids (SCFAs), 
mainly represented by acetate, propionate, and 
butyrate, reach the adult colon. It results from 
the fermentation process and carbon dioxide, 
hydrogen, methane, phenolic compounds, 
amines, ammonia. In the first part of the colon, mainly lactic acid and short chain fatty acids are 
produced, while in downstream and sigmoid colon 
phenolic and nitrate compounds are generated, 
causing colon cancer, ulcerative colitis and other gastrointestinal diseases. Short-chain fatty acids produced by fermentation have an important local 
beneficial effect, providing energy to epithelial 
cells (colonies), lowering pH, increasing calcium, 
iron and magnesium absorption, with positive 
influences on glucose and lipid metabolism in the 
liver (Besten et al., 2013).Intestinal microbiota can be found in two physiological states:
- Physiological status: when microflora is saprofit type and between it and the intestines establishes 
a symbiosis relationship, providing the human 
host with various benefits: completing digestion 
of food, degrading biliary pigments, participating 
in vitamin K biosynthesis, inhibiting growth of 
yeasts (Candida Albicans) and fungi, providing polyamines that in physiological doses feed 
enterocytes (children contribute to maturation 
of the digestive system).
- Pathological-dysbiosis status: when microflora 
becomes pathogenic, by proliferation in excess of pathogenic germs that release toxins 
(Staphylococci, Colibacilli) or damage the 
mucosal epithelium, crossing it as in case of 
Salmonella, Shigella; aerobic microorganisms developed in duodenal excess are responsible 
for diseases such as ankylosing spondylitis 
(Klebsiella), rheumatoid arthritis (Proteus 
Mirabilis), Basedow-Graves disease (Yersinia 
enterocolitica), gastroduodenal ulcer and some 
cancers (Helicobacter Pylori).
Dysbiosis-related	diseases	Diseases strongly associated with intestinal microbial imbalance are irritable bowel syn dro-
me, colon inflammatory diseases, colon cancer, 
gastroenteritis, neonatal enterocolitis, pseudo-
membranous colitis, intestinal cystitis pneuma-
CÎNPEANU et al.
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tosis, overweight, and obesity (Carding et al., 
2015).Microbiota has an essential role in shaping oral tolerance. Bacterial lipopolysaccharides facilitate induction of oral tolerance and mediate the differentiation of intestinal Th cells into cells with Th2 phenotype and possibly Th3. It is 
known that antibiotic prescription for children is associated with the occurrence of mediated IgE allergies due to the adverse effects of antibiotics 
on normal intestinal microflora. Antibiotics interfere with the installation of oral tolerance and allergy development. Recent studies have 
shown that food-specific IgG antigens circulate in 
the blood of children and adults. IgG antibodies 
appear early, before the age of 3 months and grow 
up to 5 years of age. Interestingly, over the same 
period of time, food-specific IgE antibodies are 
significantly decreasing. IgG1 and IgG4 antibodies, 
specific isotypes for eggs, wheat and cow’s milk can be detected in both healthy individuals and 
those suffering from food allergies (Castener et al., 
2018).These antibodies become dangerous when intestinal mucosa suffers lesions produced by 
pathogenic microflora, viruses, bacteria. Thus, a 
condition of inflammation that increases intesti-
nal permeability (permeable intestinal syndrome) 
occurs and allows partially digested proteins, pep-tides to reach sub-mucosal microcirculation. Im-
mune system exposure GALT = lymphoid tissue 
associated with intestine, to soluble food antigens, normally induces oral tolerance. If oral tolerance 
is compromised by dysbiosis, more than 5% of the 
population develop IgE, IgG and TGF-β mediated 
adverse immunological reactions. Thus, the com-promise of immune regulation of pathogenic mi-croorganisms response in microbiota degenerates into the occurrence of pathologies spread today: 
irritable bowel syndrome, Crohn’s disease, ulcera-
tive colitis, obesity (Cox et al., 2015).
In overweight / obese humans, low fecal bac-
terial diversity is associated with more marked 
overall adiposity and dyslipidemia, impaired glu-
cose homeostasis and higher low-grade inflam-
mation (Davis, 2016). Bacteroidetes prevalence 
is lower in obese people, with this proportion increasing along with weight loss based on a low-calorie diet. Lactobacillus and Clostridium 
species are associated with insulin resistance, with Lactobacillus positively correlated with fast-
ing glucose and glycated hemoglobin levels, where-as Clostridium showed a negative correlation with 
these parameters (Sun et al., 2018).
Certain bacteria secrete enzymes that act 
as hydrolyses of bile salts (for the formation of 
primary bile acids), being able to activate signaling pathways and gene expressions involved in the 
metabolism of lipids, carbohydrates and cholesterol in the body. The global bile acid signaling capacity is currently unclear. Bile acids are natural ligands 
for a nuclear receptor, the farnesoid X receptor, and the plasma membrane-bound bile acid receptor 
TGR5. By activating these receptors, bile acids 
regulate glucose, lipid and energy homoeostasis. Mechanisms of the interaction between microbiota 
and host that have been characterized thus far 
include an increase in energy harvest, modulation of free fatty acids—especially butyrate—of bile 
acids, lipopolysaccharides, gamma-aminobutyric 
acid (GABA), an impact on toll-like receptors, the endocannabinoid system and “metabolic endotoxinemia” as well as “metabolic infection” 
(Harsch et al., 2018).Most of the human microbiota is composed of Bacteroidetes, Firmicutes, Actinobacteria, 
Proteobacteria, and Verrucomicrobia, and 90% of all bacterial species are Bacteroidetes and 
Firmicutes (Tang et al., 2017). The composition of bacterial diversity appears to change between 
the weak and the obese, increasing the number of 
Firmicutes at the expense of Bacteroides in obese 
patients (Karlsson et al., 2013).The composition of the intestinal microbiota 
is strongly affected by dietary patterns. A high fat, high-sugar diet “in Western-style” increases the relative abundance of Firmicutes at the expense of 
Bacteroids (Turnbaugh et al., 2009).Manipulation of the microbiota may present new pathways for therapeutic interventions designed to prevent or treat obesity and associated metabolic disorders. These strategies include 
dietary manipulation, such as the use of prebiotics, 
probiotics or synbiotics, as well as transplantation of fecal microbial communities.Prebiotics - are the food ingredients that selectively stimulate the development and activity of Lactobacilli and Bifidobacteria. 
Prebiotics are low-grade carbohydrates (n=2-
60), which are indigestible because the human 
intestines do not contain the specific enzymes 
needed to depolymerize them. Prebiotics are 
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unchanged in the colon where they form the 
nutritional substrate for beneficial probiotic 
bacteria, giving them competitive advantages, 
stimulating their development, to the detriment of pathogenic bacteria. The most 
common prebiotics in human food is inulin, 
oligosaccharides, fructooligosaccharides (FOS), 
galactooligosaccharides, xilo-oligosaccharides, 
maltodextrin, polyfructosans. Daily consumption 
of 15 g fructo-oligosaccharides for 2 weeks 
significantly changes the balance of beneficial species in the human colon. FOS determines the 
increase in the number of beneficial Bifidobacteria and inhibits the development of pathogenic and 
rotting microflora of Clostridia, Fusobacteria, and Bacteroids (Slavin, 2013). Gut hormones, 
such as peptide-1 (GLP-1), play a critical role in transmitting nutritional and energy status signals from the gut to the central nervous system to 
control food intake (Lutz, 2016). In a double-
blind, placebo-controlled study in 16 adults, 
administering an inulin-like prebiotic fiber was 
associated with a significant decrease in hunger 
and significantly higher satiety after a meal and an 
increase in GLP-1 in the comparator plasma with 
a similar placebo (dextrin/maltose) tasting (Cani 
et al., 2009).
Probiotics - are living microorganisms, such as Lactobacillus acidophilus, Lactobacillus reuteri, 
Bifidobacteria, found in fresh fermented milk 
products (white sugar-free yogurt and added 
fruit or flavor, sour, kefir, beaten milk, undeclared) 
of probiotic or lyophilized food in nutritional 
supplements able to colonize the colon with 
antibacterial action on pathogenic microflora (eg 
Helicobacter Pylori), inducing beneficial effects 
on the health of the host organism (Shi et al., 
2016). A randomized controlled trial in humans demonstrated that the consumption of fermented 
milk containing Lactobacillus Gasseri probiotic 
for 12 weeks resulted in a significant reduction in abdominal visceral area compared to the control 
subjects (Kadooka et al., 2013). In contrast, other 
studies have shown no benefit of probiotics for 
the prevention/treatment of obesity (Guine et al., 
2016).Synbiotics - Foods or dietary supplements that contain both probiotic microorganisms and 
prebiotic fibers are synbiotic functional foods needed to prevent disease and the health of the body. Studies suggest that synbiotics may be effective 
in altering the composition of the microbiota. The symbiotic combination of oligofructose 
(SYN1) and Lactobacillus Rhammnosus GG and 
Bifidobacterium Lactis Bb12 enginavirinum inulin 
for 12 weeks resulted in a 16% and 18% increase in Lactobacillus and Bifidobacterium and a 31% decrease in the number of Clostridium Perfringens.The composition of human intestinal 
microbiota is in a state of dynamic evolution, 
suffering qualitative and quantitative changes 
with age. After birth, the gastrointestinal tract 
is sterile, being progressively colonized by 
Bifidobacteria, E. Coli, Streptococci, optionally 
anaerobic. In the upper part of the colon, 
microflora is predominantly anaerobic, consisting of Enterobacteria, Streptococci, Staphylococci, 
Lactobacilli, Propionylbacteria and Bacilli. In 
the lower part of the colon, microflora becomes 
strictly anaerobic, consisting of Bacteroides, 
Eubacterium, Peptococci, Bifidobacterium, 
Fusobacterium, Clostridium species (Shi et al., 
2016). Food is the main bearer of information 
taken from the environment, interacting with its own genetic information of the body. Dysbiosis as a pathological condition is today unconscious and therefore undiagnosed and untreated. Ignoring 
dysbiosis, however, has serious health and long-
term consequences, generating a polymorphic 
pathology such as irritable bowel syndrome, 
Helicobacter pylori infection, hepatic cirrhosis, 
non-alcoholic steatohepatitis, ankylosing 
spondylitis, Alzheimer’s disease, eating disorders, 
obesity, metabolic syndrome and type 2 diabetes.
Whole	grains	
Cereals are the basis of the diet of the planet’s 
inhabitants, being represented by eight basic 
cereals: wheat, corn, rice, barley, sorghum, oats, 
rye, millet. The change in lifestyle lifestyle has led to a high consumption of grain as well as 
industrially deficient in the vitamin B group.Whole grains have great nutritional and 
bioactive properties due to their fractions, bran 
and germ, which contain unique health-promoting 
bioactive components exhibiting significant antioxidant activity [18] with ferulic acid as its 
major antioxidant. Grain bran is a major source of 
phenolic acids - antioxidants, fibers and minerals 
(Calinoiu et al., 2018). Whole grains has been 
shown to reduce the risk of metabolic disease, possibly via modulation of the gut microbiota. 
CÎNPEANU et al.
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A recent meta-analysis concluded that adults consuming more than three servings of whole 
grain had a consistently lower risk of obesity (Ye et 
al., 2012). Consuming whole grains is postulated 
to decrease chronic disease risk, in part due 
to beneficial effects on body weight regulation 
(Jonnalagadda et al., 2011). Observational studies 
strongly suggest that consuming ∼3 servings/d 
whole grain (∼48 g) is associated with lower BMI and central adiposity relative to low or no whole 
grain consumption, and higher WG intakes may 
attenuate weight gain (Calinoiu et al., 2018). There have been several studies that report changes in the gut microbiota following a whole grain intervention. Most studies report only modest to 
no changes in gut microbiota composition (Cooper 
et al., 2017).Diet therapy is the treatment of choice for dysbiosis. Changing dietary habits sustain by a proper educational community intervention 
(Guine et al., 2016) and adopting a diet rich in 
live foods with high levels of active food enzymes, 
fruits, vegetables, seeds, nuts, germs, and herbs, consumed in the raw state and in their emergence season can restore a physiological microbiota 
(Badau et al., 2018).
Conclusion
In conclusion, negative influence of the microbiota by consumption of industrially-added 
food, especially with artificial preservatives, but 
also by inadequate antibiotic treatments, leads 
to an imbalance in microbiota concretized in the state of dysbiosis. The human body now comes in 
contact with over 40,000 different “toxins” (heavy 
metals, pesticide residues, chemical fertilizers, 
antibiotics, hormones, genetically modified 
organisms, plastics, motor vehicle emissions, food 
additives, artificial flavors, cosmetic compounds, 
products of chemical-industrial activity, artificial 
electromagnetic fields, etc.). Thus, digestive 
system, liver, kidneys, or immune system are 
overstretched and often overcome, leading 
to general intoxication, enzyme blocking, and ultimately disease.In order to return to the normal state of oral-
gastrointestinal microflora, a healthy lifestyle must 
be followed, consuming raw, less processed foods, 
incorrect use of antibiotics, mouth disinfectants and other substances or foods that can affect their balance.
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